Home > > > > > Report Detail

Global Human Coagulation Factor VIII Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 09-Nov-2021
No. of pages: 95

The Human Coagulation Factor VIII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Human Coagulation Factor VIII size is estimated to be XX million in 2021 from USD 9829.6 million in 2020, with a change of XX% between 2020 and 2021. The global Human Coagulation Factor VIII market size is expected to grow at a CAGR of 6.0% for the next five years.

Market segmentation

Human Coagulation Factor VIII market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Recombinant Factor VIII

- Plasma-derived Factor VIII

Market segment by Application can be divided into

- Hemophilia A

- Spontanous / Trauma

- Surgical

- Other

The key market players for global Human Coagulation Factor VIII market are listed below:

- Shire (Baxter)

- Bayer

- CSL

- Pfizer

- Grifols

- Biogen

- Octapharma

- NovoNordisk

- Greencross

- Kedrion

- BPL

- Hualan Bio

- RAAS

Market segment by Region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Human Coagulation Factor VIII product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Human Coagulation Factor VIII, with price, sales, revenue and global market share of Human Coagulation Factor VIII from 2019 to 2021.

Chapter 3, the Human Coagulation Factor VIII competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Human Coagulation Factor VIII breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Human Coagulation Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Human Coagulation Factor VIII sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Human Coagulation Factor VIII Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Human Coagulation Factor VIII Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Coagulation Factor VIII Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Coagulation Factor VIII Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Global Human Coagulation Factor VIII Market Size & Forecast
1.4.1 Global Human Coagulation Factor VIII Sales in Value (2016-2026))
1.4.2 Global Human Coagulation Factor VIII Sales in Volume (2016-2026)
1.4.3 Global Human Coagulation Factor VIII Price by Type (2016-2026) & (USD/Bottle)
1.5 Global Human Coagulation Factor VIII Production Capacity Analysis
1.5.1 Global Human Coagulation Factor VIII Total Production Capacity (2016-2026)
1.5.2 Global Human Coagulation Factor VIII Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Coagulation Factor VIII Market Drivers
1.6.2 Human Coagulation Factor VIII Market Restraints
1.6.3 Human Coagulation Factor VIII Trends Analysis
2 Manufacturers Profiles
2.1 Shire (Baxter)
2.1.1 Shire (Baxter) Details
2.1.2 Shire (Baxter) Major Business
2.1.3 Shire (Baxter) Human Coagulation Factor VIII Product and Services
2.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Human Coagulation Factor VIII Product and Services
2.2.4 Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Human Coagulation Factor VIII Product and Services
2.3.4 CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Human Coagulation Factor VIII Product and Services
2.4.4 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Human Coagulation Factor VIII Product and Services
2.5.4 Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Human Coagulation Factor VIII Product and Services
2.6.4 Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Octapharma
2.7.1 Octapharma Details
2.7.2 Octapharma Major Business
2.7.3 Octapharma Human Coagulation Factor VIII Product and Services
2.7.4 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 NovoNordisk
2.8.1 NovoNordisk Details
2.8.2 NovoNordisk Major Business
2.8.3 NovoNordisk Human Coagulation Factor VIII Product and Services
2.8.4 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Greencross
2.9.1 Greencross Details
2.9.2 Greencross Major Business
2.9.3 Greencross Human Coagulation Factor VIII Product and Services
2.9.4 Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Kedrion
2.10.1 Kedrion Details
2.10.2 Kedrion Major Business
2.10.3 Kedrion Human Coagulation Factor VIII Product and Services
2.10.4 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 BPL
2.11.1 BPL Details
2.11.2 BPL Major Business
2.11.3 BPL Human Coagulation Factor VIII Product and Services
2.11.4 BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Hualan Bio
2.12.1 Hualan Bio Details
2.12.2 Hualan Bio Major Business
2.12.3 Hualan Bio Human Coagulation Factor VIII Product and Services
2.12.4 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 RAAS
2.13.1 RAAS Details
2.13.2 RAAS Major Business
2.13.3 RAAS Human Coagulation Factor VIII Product and Services
2.13.4 RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Human Coagulation Factor VIII Sales by Manufacturer
3.1 Global Human Coagulation Factor VIII Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Coagulation Factor VIII Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Coagulation Factor VIII
3.4 Market Concentration Rate
3.4.1 Top 3 Human Coagulation Factor VIII Manufacturer Market Share
3.4.2 Top 6 Human Coagulation Factor VIII Manufacturer Market Share
3.5 Global Human Coagulation Factor VIII Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Coagulation Factor VIII Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Coagulation Factor VIII Market Size by Region
4.1.1 Global Human Coagulation Factor VIII Sales in Volume by Region (2016-2026)
4.1.2 Global Human Coagulation Factor VIII Revenue by Region (2016-2026)
4.2 North America Human Coagulation Factor VIII Revenue (2016-2026)
4.3 Europe Human Coagulation Factor VIII Revenue (2016-2026)
4.4 Asia-Pacific Human Coagulation Factor VIII Revenue (2016-2026)
4.5 South America Human Coagulation Factor VIII Revenue (2016-2026)
4.6 Middle East and Africa Human Coagulation Factor VIII Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Coagulation Factor VIII Sales in Volume by Type (2016-2026)
5.2 Global Human Coagulation Factor VIII Revenue by Type (2016-2026)
5.3 Global Human Coagulation Factor VIII Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Coagulation Factor VIII Sales in Volume by Application (2016-2026)
6.2 Global Human Coagulation Factor VIII Revenue by Application (2016-2026)
6.3 Global Human Coagulation Factor VIII Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Coagulation Factor VIII Sales by Type (2016-2026)
7.2 North America Human Coagulation Factor VIII Sales by Application (2016-2026)
7.3 North America Human Coagulation Factor VIII Market Size by Country
7.3.1 North America Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
7.3.2 North America Human Coagulation Factor VIII Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Coagulation Factor VIII Sales by Type (2016-2026)
8.2 Europe Human Coagulation Factor VIII Sales by Application (2016-2026)
8.3 Europe Human Coagulation Factor VIII Market Size by Country
8.3.1 Europe Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Coagulation Factor VIII Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Coagulation Factor VIII Sales by Type (2016-2026)
9.2 Asia-Pacific Human Coagulation Factor VIII Sales by Application (2016-2026)
9.3 Asia-Pacific Human Coagulation Factor VIII Market Size by Region
9.3.1 Asia-Pacific Human Coagulation Factor VIII Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Coagulation Factor VIII Sales by Type (2016-2026)
10.2 South America Human Coagulation Factor VIII Sales by Application (2016-2026)
10.3 South America Human Coagulation Factor VIII Market Size by Country
10.3.1 South America Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
10.3.2 South America Human Coagulation Factor VIII Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Coagulation Factor VIII Sales by Type (2016-2026)
11.2 Middle East & Africa Human Coagulation Factor VIII Sales by Application (2016-2026)
11.3 Middle East & Africa Human Coagulation Factor VIII Market Size by Country
11.3.1 Middle East & Africa Human Coagulation Factor VIII Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Coagulation Factor VIII Typical Distributors
12.3 Human Coagulation Factor VIII Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Human Coagulation Factor VIII Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Coagulation Factor VIII Revenue by Application, (USD Million), 2021-2026
Table 3. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 4. Shire (Baxter) Major Business
Table 5. Shire (Baxter) Human Coagulation Factor VIII Product and Services
Table 6. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Human Coagulation Factor VIII Product and Services
Table 10. Bayer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Human Coagulation Factor VIII Product and Services
Table 14. CSL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Human Coagulation Factor VIII Product and Services
Table 18. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Grifols Basic Information, Manufacturing Base and Competitors
Table 20. Grifols Major Business
Table 21. Grifols Human Coagulation Factor VIII Product and Services
Table 22. Grifols Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Human Coagulation Factor VIII Product and Services
Table 26. Biogen Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Octapharma Basic Information, Manufacturing Base and Competitors
Table 28. Octapharma Major Business
Table 29. Octapharma Human Coagulation Factor VIII Product and Services
Table 30. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 32. NovoNordisk Major Business
Table 33. NovoNordisk Human Coagulation Factor VIII Product and Services
Table 34. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Greencross Basic Information, Manufacturing Base and Competitors
Table 36. Greencross Major Business
Table 37. Greencross Human Coagulation Factor VIII Product and Services
Table 38. Greencross Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kedrion Basic Information, Manufacturing Base and Competitors
Table 40. Kedrion Major Business
Table 41. Kedrion Human Coagulation Factor VIII Product and Services
Table 42. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. BPL Basic Information, Manufacturing Base and Competitors
Table 44. BPL Major Business
Table 45. BPL Human Coagulation Factor VIII Product and Services
Table 46. BPL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 48. Hualan Bio Major Business
Table 49. Hualan Bio Human Coagulation Factor VIII Product and Services
Table 50. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. RAAS Basic Information, Manufacturing Base and Competitors
Table 52. RAAS Major Business
Table 53. RAAS Human Coagulation Factor VIII Product and Services
Table 54. RAAS Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Human Coagulation Factor VIII Sales by Manufacturer (2019-2021e) & (K Bottles)
Table 56. Global Human Coagulation Factor VIII Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Human Coagulation Factor VIII, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Human Coagulation Factor VIII Production Capacity by Company, (K Bottles): 2020 VS 2021
Table 59. Head Office and Human Coagulation Factor VIII Production Site of Key Manufacturer
Table 60. Human Coagulation Factor VIII New Entrant and Capacity Expansion Plans
Table 61. Human Coagulation Factor VIII Mergers & Acquisitions in the Past Five Years
Table 62. Global Human Coagulation Factor VIII Sales by Region (2016-2021e) & (K Bottles)
Table 63. Global Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles)
Table 64. Global Human Coagulation Factor VIII Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Human Coagulation Factor VIII Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 67. Global Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 68. Global Human Coagulation Factor VIII Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Human Coagulation Factor VIII Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Human Coagulation Factor VIII Price by Type (2016-2021e) & (USD/Bottle)
Table 71. Global Human Coagulation Factor VIII Price by Type (2021-2026) & (USD/Bottle)
Table 72. Global Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 73. Global Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 74. Global Human Coagulation Factor VIII Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Human Coagulation Factor VIII Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Human Coagulation Factor VIII Price by Application (2016-2021e) & (USD/Bottle)
Table 77. Global Human Coagulation Factor VIII Price by Application (2021-2026) & (USD/Bottle)
Table 78. North America Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 79. North America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 80. North America Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 83. North America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 84. North America Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 85. North America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 86. Europe Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 87. Europe Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 88. Europe Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 91. Europe Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 92. Europe Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 93. Europe Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 94. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2016-2021e) & (K Bottles)
Table 95. Asia-Pacific Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles)
Table 96. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Human Coagulation Factor VIII Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 99. Asia-Pacific Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 100. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 101. Asia-Pacific Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 102. South America Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 103. South America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 104. South America Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 107. South America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 108. South America Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 109. South America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 110. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2016-2021e) & (K Bottles)
Table 111. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles)
Table 112. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2016-2021e) & (K Bottles)
Table 115. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles)
Table 116. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2016-2021e) & (K Bottles)
Table 117. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Human Coagulation Factor VIII Typical Distributors
Table 121. Human Coagulation Factor VIII Typical Customers
List of Figures
Figure 1. Human Coagulation Factor VIII Picture
Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2020
Figure 3. Recombinant Factor VIII
Figure 4. Plasma-derived Factor VIII
Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2020
Figure 6. Hemophilia A
Figure 7. Spontanous / Trauma
Figure 8. Surgical
Figure 9. Other
Figure 10. Global Human Coagulation Factor VIII Market Size, (USD Million) & (K Bottles): 2020 VS 2021 VS 2026
Figure 11. Global Human Coagulation Factor VIII Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Human Coagulation Factor VIII Sales (2016-2026) & (K Bottles)
Figure 13. Global Human Coagulation Factor VIII Price by Type (2016-2026) & (USD/Bottle)
Figure 14. Global Human Coagulation Factor VIII Production Capacity (2016-2026) & (K Bottles)
Figure 15. Global Human Coagulation Factor VIII Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Human Coagulation Factor VIII Market Drivers
Figure 17. Human Coagulation Factor VIII Market Restraints
Figure 18. Human Coagulation Factor VIII Market Trends
Figure 19. Global Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2020
Figure 20. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2020
Figure 21. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Human Coagulation Factor VIII Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Human Coagulation Factor VIII Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2026)
Figure 25. Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2026)
Figure 26. North America Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 27. Europe Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 29. South America Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Human Coagulation Factor VIII Revenue (2016-2026) & (USD Million)
Figure 31. Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 32. Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2026)
Figure 33. Global Human Coagulation Factor VIII Price by Type (2016-2026) & (USD/Bottle)
Figure 34. Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 35. Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2026)
Figure 36. Global Human Coagulation Factor VIII Price by Application (2016-2026) & (USD/Bottle)
Figure 37. North America Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 38. North America Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 39. North America Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 40. North America Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 41. United States Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 45. Europe Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 46. Europe Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 47. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 48. Germany Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Human Coagulation Factor VIII Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2016-2026)
Figure 57. China Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 64. South America Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 65. South America Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 66. South America Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Human Coagulation Factor VIII Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
  • Global Human Coagulation Factor VII Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83
    According to our LPI (LP Information) latest study, the global Human Coagulation Factor VII market size was valued at US$ 2232.8 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VII is forecast to a readjusted size of US$ 4339.6 million by 2030 with a CAGR of 10.0% during review period. The research report highlights the growth potential of the global Human Coagulation Factor VII market. Human Coagulation Factor VII are expected to show stable growt......
  • Global Human Coagulation Factor VIII Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Human Coagulation Factor VIII market size was valued at US$ 10010 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VIII is forecast to a readjusted size of US$ 15590 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Human Coagulation Factor VIII market. Human Coagulation Factor VIII are expected to show stable grow......
  • Global D-Dimer Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 97
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global D-dimer market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - F. Hoffman-La Roche - Beckman Coulter - Abbott - Bio/Data - Becton Dickinson - Sysmex - Siemens Healthcare - Trinit......
  • Global Human Coagulation Factor VII Professional Survey Report 2023, Forecast to 2028
    Published: 09-Nov-2023        Price: US 3280 Onwards        Pages: 104
    Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......
  • Global Human Coagulation Factor VII Market Research Report 2023, Forecast to 2028
    Published: 09-Nov-2023        Price: US 2680 Onwards        Pages: 167
    Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......
  • Global Human Coagulation Factor Viii Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Aug-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Human Coagulation Factor Viii market: According to our latest research, the global Human Coagulation Factor Viii market looks promising in the next 5 years. As of 2022, the global Human Coagulation Factor Viii market was estimated at USD 9757.48 million, and it's anticipated to reach USD 17207.33 million in 2028, with a CAGR of 9.92% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehe......
  • Global Coagulation Tests Market Insights, Forecast to 2029
    Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 109
    Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......
  • Global D-dimer Market Insights, Forecast to 2029
    Published: 14-Jun-2023        Price: US 4900 Onwards        Pages: 107
    The global D-dimer market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during......
  • Global Coagulation Tests Market Research Report 2023
    Published: 11-Apr-2023        Price: US 2900 Onwards        Pages: 86
    Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs